Fundraising FoxDicerna Pharmaceuticals
5 known investors
Find your way into Dicerna Pharmaceuticals
Sign up to see every warm intro you have to Dicerna Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dicerna Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A pharmaceutical company developing treatments for serious chronic diseases with a focus on long-term health solutions and improving medicine access and affordability globally. The company conducts research and development, collaborates with scientists and biotech innovators, and has reached millions of patients through its innovative therapeutic approaches.
Investors · 5
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: Ridgeback Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $184.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Dicerna Pharmaceuticals do?
- A pharmaceutical company developing treatments for serious chronic diseases with a focus on long-term health solutions and improving medicine access and affordability globally. The company conducts research and development, collaborates with scientists and biotech innovators, and has reached millions of patients through its innovative therapeutic approaches.
- Who are Dicerna Pharmaceuticals's investors?
- Dicerna Pharmaceuticals's investors include Access Biotechnology, Bain Capital Life Sciences, Ridgeback Capital, Oxford Bioscience Partners, RA Capital.